1
Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome
Condition(s): Muckle Wells Syndrome Last Updated: July 31, 2012Completed
13 Clinical Trials for: “Wells Syndrome”, Page 1 of 1
Hide Studies Not Seeking New Volunteers
2
A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease
Condition(s): Muckle Wells Syndrome; Autoinflammatory; Behcet's Disease Last Updated: December 30, 2011Withdrawn
3
Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)
Condition(s): Muckle-Wells Syndrome; Schnitzler Syndrome Last Updated: May 30, 2012Completed
4
Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
Condition(s): Cryopyrin-associated Periodic Syndromes:; Familial Cold Autoinflammatory Syndrome; Muckle Wells Syndrome; Neonatal Onset Multisystem Inflammatory Disease Last Updated: July 24, 2012Completed
5
Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
Condition(s): Cryopyrin-associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle-Wells Syndrome; Neonatal Onset Multisystem Inflammatory Disease Last Updated: April 10, 2012Recruiting
6
Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
Condition(s): Cryopyrin-associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle-Wells Syndrome; Neonatal Onset Multisystem Inflammatory Disease Last Updated: May 7, 2012Recruiting
7
Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase
Condition(s): Cryopyrin-associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle-Wells Syndrome; Neonatal Onset Multisystem Inflammatory Disease Last Updated: January 31, 2013Completed
8
Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
Condition(s): Familial Cold Autoinflammatory Syndrome (FCAS); Familial Cold Urticaria; Muckle-Wells Syndrome (MWS); Genetic Diseases, Inborn Last Updated: December 1, 2011Completed
9
Internleukin-1 Trap to Treat Autoinflammatory Disease
Condition(s): Inflammation; Familial Mediterranean Fever; Still's Disease, Adult-Onset Last Updated: February 25, 2011Completed
10
Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms
Condition(s): NALP3 Mutation Last Updated: February 16, 2009Completed
11
Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
Condition(s): Periodic Disease Last Updated: May 1, 2013Recruiting
12
The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada
Condition(s): Cryopyrin Associated Periodic Syndrome Last Updated: September 30, 2012Completed
13
Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients
Condition(s): Cryopyrin-associated Periodic Syndromes (CAPS); Familial Cold Autoinflam Syn (FCAS); Muckle-wells Syn (MWS); Neonatal Onset Multisystem Inflam Disease (NOMID) Last Updated: April 27, 2012Recruiting
